ExpreS2ion Biotech Holding AB (publ)
EXPRS2.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.78M
Close$
Share Statistics
| Market cap | $2.78 Million |
|---|---|
| Enterprise Value | $-30,145,399.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.39 |
| Beta | 2.21 |
| Outstanding Shares | 36,008,547 |
Return
| Return on Equity | -85.96% |
|---|---|
| Return on Assets | -62.14% |
| Return on Invested Capital | -145.14% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | 4.94 |
| Price to Sales | - |
| Price to Book Ratio | 1.09 |
| Enterprise Value to Revenue | -7.86 |
| Enterprise Value to EBIT | 0.48 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$2.01 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.94 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ExpreS2ion Biotech Holding AB (publ)
19 employees
CEO: Bent U. Frandsen Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's develo...